Texas AG Sends Civil Investigative Demands to Two Drug Makers Over Promotion of Hormone Blockers

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Texas AG Sends Civil Investigative Demands to Two Drug Makers Over Promotion of Hormone Blockers

J.W. Schomisch

April 6, 2022 at 05:20 PM EST

The Texas Attorney General’s Office sent Civil Investigative Demands (CIDs) to two pharmaceutical manufacturers regarding their advertising and promotion of hormone blockers. The CIDs to AbbVie Inc. and Endo Pharmaceuticals Inc. are part of an investigation to determine whether the manufacturers “deceptively advertised and promoted hormone blockers for unapproved uses without... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Texas AG Sends Civil Investigative Demands to Two Drug Makers Over Promotion of Hormone Blockers

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT